Yun‐Kai Lin

527 total citations
15 papers, 340 citations indexed

About

Yun‐Kai Lin is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Yun‐Kai Lin has authored 15 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Surgery and 5 papers in Cancer Research. Recurrent topics in Yun‐Kai Lin's work include Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), RNA modifications and cancer (4 papers) and Ferroptosis and cancer prognosis (4 papers). Yun‐Kai Lin is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), RNA modifications and cancer (4 papers) and Ferroptosis and cancer prognosis (4 papers). Yun‐Kai Lin collaborates with scholars based in China, United States and Czechia. Yun‐Kai Lin's co-authors include Liwei Dong, Yexiong Tan, Tianyi Jiang, Hongyang Wang, Yufei Pan, Xiaoqiang Cui, Yuanyuan Shi, Zhiwen Ding, Chun Yang and Yufei Pan and has published in prestigious journals such as Nature Communications, Gastroenterology and Hepatology.

In The Last Decade

Yun‐Kai Lin

15 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yun‐Kai Lin China	11	190	108	90	74	73	15	340
Marko Kornmann Germany	10	179 0.9×	78 0.7×	178 2.0×	70 0.9×	40 0.5×	26	375
Qiliang Lu China	11	222 1.2×	136 1.3×	70 0.8×	29 0.4×	64 0.9×	30	365
Jiangsheng Huang China	11	136 0.7×	92 0.9×	67 0.7×	67 0.9×	33 0.5×	24	294
Moubin Lin China	10	135 0.7×	118 1.1×	109 1.2×	50 0.7×	60 0.8×	18	316
Yuqiang Shan China	9	178 0.9×	112 1.0×	81 0.9×	48 0.6×	63 0.9×	30	359
Wenzhou Ding China	8	183 1.0×	182 1.7×	143 1.6×	73 1.0×	67 0.9×	22	403
Jin‐Ling Duan China	13	265 1.4×	139 1.3×	105 1.2×	45 0.6×	52 0.7×	29	407
Dingcheng Zheng China	8	207 1.1×	214 2.0×	112 1.2×	55 0.7×	89 1.2×	10	377
Yaozhen Pan China	7	176 0.9×	92 0.9×	91 1.0×	26 0.4×	46 0.6×	22	284

Countries citing papers authored by Yun‐Kai Lin

Since Specialization

Citations

This map shows the geographic impact of Yun‐Kai Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yun‐Kai Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yun‐Kai Lin more than expected).

Fields of papers citing papers by Yun‐Kai Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yun‐Kai Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yun‐Kai Lin. The network helps show where Yun‐Kai Lin may publish in the future.

Co-authorship network of co-authors of Yun‐Kai Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yun‐Kai Lin. A scholar is included among the top collaborators of Yun‐Kai Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yun‐Kai Lin. Yun‐Kai Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Lin, Yun‐Kai, Yufei Pan, Tianyi Jiang, et al.. (2025). Blocking the SIRPα-CD47 axis promotes macrophage phagocytosis of exosomes derived from visceral adipose tissue and improves inflammation and metabolism in mice. Journal of Biomedical Science. 32(1). 31–31. 3 indexed citations

Pan, Yufei, Lin Zhong, Min Wang, et al.. (2024). PTEN status determines therapeutic vulnerability to celastrol in cholangiocarcinoma. Phytomedicine. 131. 155790–155790. 1 indexed citations

Li, Xin, Yufei Pan, Yibin Chen, et al.. (2024). Arsenic trioxide augments immunogenic cell death and induces cGAS-STING-IFN pathway activation in hepatocellular carcinoma. Cell Death and Disease. 15(4). 300–300. 28 indexed citations

Lin, Yun‐Kai, Qing Wang, Jiang Li, et al.. (2024). Mechanism exploration of Zoledronic acid combined with PD-1 in the treatment of hepatocellular carcinoma. Cancer Immunology Immunotherapy. 73(4). 62–62. 3 indexed citations

Ding, Zhiwen, Yufei Pan, Tianyi Jiang, et al.. (2023). URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers. Nature Communications. 14(1). 6269–6269. 49 indexed citations

Jiang, Tianyi, Tao Lü, Hui Wang, et al.. (2023). Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma. Frontiers in Immunology. 14. 1166497–1166497. 51 indexed citations

Jiang, Tianyi, Yufei Pan, Yun‐Kai Lin, et al.. (2023). PTEN deficiency facilitates gemcitabine efficacy in cancer by modulating the phosphorylation of PP2Ac and DCK. Science Translational Medicine. 15(704). eadd7464–eadd7464. 15 indexed citations

Jiang, Tianyi, Yuanyuan Shi, Xiaoqiang Cui, et al.. (2022). PTEN Deficiency Facilitates Exosome Secretion and Metastasis in Cholangiocarcinoma by Impairing TFEB-mediated Lysosome Biogenesis. Gastroenterology. 164(3). 424–438. 59 indexed citations

Shi, Yuanyuan, Xiaoqiang Cui, Tianyi Jiang, et al.. (2022). The therapeutic effect of KSP inhibitors in preclinical models of cholangiocarcinoma. Cell Death and Disease. 13(9). 799–799. 4 indexed citations

10.

Wang, Di, Yun‐Kai Lin, Feihong Xu, et al.. (2022). SIRPα maintains macrophage homeostasis by interacting with PTK2B kinase in Mycobacterium tuberculosis infection and through autophagy and necroptosis. EBioMedicine. 85. 104278–104278. 20 indexed citations

11.

Jiang, Tianyi, Yufei Pan, Yun‐Kai Lin, et al.. (2020). PTEN status determines chemosensitivity to proteasome inhibition in cholangiocarcinoma. Science Translational Medicine. 12(562). 34 indexed citations

12.

Jiang, Tianyi, Fang Zheng, Xiaoqiang Cui, et al.. (2020). PTEN deficiency facilitates the therapeutic vulnerability to proteasome inhibitor bortezomib in gallbladder cancer. Cancer Letters. 501. 187–199. 15 indexed citations

13.

Jiang, Tianyi, Yuanyuan Shi, Yufei Pan, et al.. (2019). RPB5‐Mediating Protein Promotes Cholangiocarcinoma Tumorigenesis and Drug Resistance by Competing With NRF2 for KEAP1 Binding. Hepatology. 71(6). 2005–2022. 20 indexed citations

14.

Jiang, Tianyi, Yun‐Kai Lin, Yuanyuan Shi, et al.. (2019). Six2 is negatively correlated with prognosis and facilitates epithelial-mesenchymal transition via TGF-β/Smad signal pathway in hepatocellular carcinoma. Hepatobiliary & pancreatic diseases international. 18(6). 525–531. 12 indexed citations

15.

Lin, Yun‐Kai, Fang Zheng, Tianyi Jiang, et al.. (2018). Combination of Kras activation and PTEN deletion contributes to murine hepatopancreatic ductal malignancy. Cancer Letters. 421. 161–169. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact